Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic-Myeloproliferative Diseases × durvalumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 12 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Breast Neoplasms 10 Small Cell Lung Carcinoma 8 Urinary Bladder Neoplasms 7 Recurrence 6 Prostatic Neoplasms 6 Neoplasms 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Neoplasm Metastasis 4 Recurrent Squamous Cell Lung Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Mesothelioma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urothelial Cancer 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Busulfan 11 Mycophenolic Acid 10 Tacrolimus 9 Methotrexate 8 Cyclosporine 8 Antilymphocyte Serum 8 Etoposide 7 Melphalan 5 Cytarabine 5 Cyclosporins 5 Sirolimus 4 Radiotherapy 4 Rituximab 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ruxolitinib 2 Granulocyte Colony-Stimulating Factor 2 Flow Cytometry 2 Carmustine 2 Carboplatin 2 veliparib 1 vatalanib 1 treosulfan 1 sargramostim 1 rasburicase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡